General Atlantic

General Atlantic is a leading global growth investor with over four decades of experience, providing capital and strategic support...

On January 9, 2025, General Atlantic announced the launch of Verdiva Bio, a new clinical-stage cardiometabolic company, with over $410 million in Series A financing...

General Atlantic-backed biotech start-up Verdiva Bio secures $410 million in initial funding round...

General Atlantic has launched a Sustainable Infrastructure strategy by acquiring Actis, a global sustainable infrastructure investor...

General Atlantic led a $500M Series E round for Insider, resulting in a 56x MOIC and 63% IRR for early investors...

General Atlantic has completed the acquisition of Actis as of October 2, 2024...

General Atlantic has unveiled an evolved brand identity emphasizing its core values of depth, dynamism, and a focus on future opportunities...